Full cohort | Without PCP | With PCP | p | |
---|---|---|---|---|
n | 83 | 57 | 26 | |
Female (%) | 70 (84) | 47 | 23 | 0.746 |
Ethnicity (Hispanic:Asian:White) (%) | 70:8:5 (84:10:6) | 46:7:1 | 24:1:1 | |
Median age at presentation (yr) (IQR) | 48 (41–57) | 48 (40–59) | 46 (41–55) | 0.776 |
Fundinga (%) | 48 (58) | 29 (51) | 19 (73) | 0.057 |
Medicare | 4 | 3 | 1 | |
Medicaid | 22 | 15 | 7 | |
County Funding | 22 | 9 | 13 | |
MUA/HPSAb (%) | 42 (51) | 31 | 11 | 0.307 |
Poverty Rate of Zip Code (IQR) | 22.1 (15.6-26.2) | 24.5 (15.6-29) | 19.4 (12.9- 23.8) | 0.267 |
Median Income of Zip Code (IQR) | 43364 (38903–55784) | 43364 (35836–53738) | 45556 (42712–57586) | 0.160 |
Median follow-up (mo) (IQR) | 21 (7.5-65.7) | 15 (6.5-61) | 44 (11–89) | 0.209 |
Lost to follow-up (%) | 26 (31) | 23 (40) | 3 (12) | 0.010 |
Presented with Decompensation (%) | 6 (7) | 6 (11) | 0 (0) | 0.170 |
Acute Disease (Symptoms < 2 week) (%) | 37 (45) | 26 (46) | 11 (42) | 0.779 |
Cirrhosis at presentation (%) | 32 (39) | 26 (46) | 6 (23) | 0.05 |
Any decompensation (%) | 26 (31) | 21 (37) | 5 (19) | 0.109 |
ANA >1:40 (%) | 59 (71) | 37 (65) | 22 (85) | 0.075 |
SMA (%) | 58 (70) | 38 (67) | 20 (77) | 0.557 |
LKM (60 checked) (%) | 4 (5) | 3 (5) | 1 (4) | 0.762 |
ANA or SMA (%) | 75 (90) | 50 (88) | 25 (96) | 0.425 |
Other autoimmune disease (e.g. lupus, rheumatoid arthritis, etc.) (%) | 23 (28) | 12 (21) | 11 (42) | 0.048 |
AST (IQR) | 429 (157–1248) | 487 (136–1329) | 418 (168–1074) | 0.871 |
ALT (IQR) | 657 (152–1450) | 700 (179–1564) | 427 (143–942) | 0.525 |
Bilirubin (IQR) | 5.2 (1.5-21.2) | 11.9 (2.1-22.9) | 2.1 (0.7-10.3) | 0.040 |
Albumin (IQR) | 2.5 (1.8-3.2) | 2.4 (1.8-2.8) | 3.1 (2.1-3.5) | 0.019 |
INR (IQR) | 1.3 (1.1-1.8) | 1.4 (1.1-2.0) | 1.1 (1.0-1.3) | 0.007 |
Platelets (IQR) | 160 (90–120) | 146 (84–202) | 174 (114–219) | 0.009 |
IgG (IQR) | 1830 (1500–2350) | 1820 (1475–2530) | 1850 (1500–2170) | 0.871 |
MELD Score (in patients with cirrhosis) (IQR) | 17.1 (11.5-24.0) | 17.9 (13.0-24.5) | 13.9 (9.2-19.4) | 0.244 |
Flu-like symptoms (%) | 22 (27) | 15 (26) | 7 (27) | 0.954 |
Abdominal pain (%) | 36 (43) | 24 (42) | 12 (46) | 0.730 |
Jaundice (%) | 54 (65) | 41 (72) | 13 (50) | 0.052 |
Pruritis (%) | 6 (7) | 4 (7) | 1 (4) | 0.660 |
GI bleed (%) | 6 (7) | 6 (11) | 0 (0) | 0.170 |
Ascites (%) | 23 (28) | 20 (35) | 3 (11) | 0.034 |
Encephalopathy (%) | 10 (12) | 8 (14) | 2 (8) | 0.494 |